Breast biopsy and race/ethnicity among women without breast cancer

Cancer Detection and Prevention

Volumn 30, Issue 2, 2006, Pages 129-133

  Jacobson, Judith S ^a,b   Grann, Victor R ^a,b   Hershman, Dawn ^a,b   Troxel, Andrea B ^c   Li, Huiling ^a,b   Neugut, Alfred I ^a,b  

^a Department of Medicine   (United States)

^b College of Physicians and Surgeons ^*  (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Biopsy; Breast cancer; Disparities; Hyperplasia; Insurance; Locular carcinoma in situ; Mammography; National Surgical Adjuvant Breast and Bowel Project; NSABP; Prevention; Race ethnicity; Raloxifene; Risk assessment; STAR trial; Survival; Tamoxifen

Indexed keywords

RALOXIFENE; TAMOXIFEN;

ADULT; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER RISK; CONTROLLED STUDY; DEMOGRAPHY; EDUCATION; ETHNIC DIFFERENCE; ETHNOLOGY; FEMALE; HEALTH INSURANCE; HUMAN; HUMAN TISSUE; MAMMOGRAPHY; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT;

ADULT; AFRICAN AMERICANS; AGED; BIOPSY; BREAST; BREAST NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; INSURANCE, HEALTH; LOGISTIC MODELS; MIDDLE AGED; MINORITY GROUPS; QUESTIONNAIRES; RISK ASSESSMENT; SOCIOECONOMIC FACTORS;

EID: 33646770668     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2006.02.002     Document Type: Article

References (29)

1. Smith-Bindman R., Chu P.W., Miglioretti D.L., Sickles E.A., Blanks R., Ballard-Barbash R., et al. Comparison of screening mammography in the United States and the United Kingdom. JAMA 290 16 (2003) 2129-2137
2. Burhenne L.J., Hislop T.G., and Burhenne H.J. The British Columbia Mammography Screening Program: evaluation of the first 15 months. AJR Am J Roentgenol 158 1 (1992) 45-49
3. Kerner J.F., Yedidia M., Padgett D., Muth B., Washington K.S., Tefft M., et al. Realizing the promise of breast cancer screening: clinical follow-up after abnormal screening among Black women. Prev Med Aug 37 2 (2003) 92-101
4. Chang S.W., Kerlikowske K., Napoles-Springer A., Posner S.F., Sickles E.A., and Perez-Stable E.J. Racial differences in timeliness of follow-up after abnormal screening mammography. Cancer 78 7 (1996) 1395-1402
5. Strzelczyk J.J., and Dignan M.B. Disparities in adherence to recommended followup on screening mammography: interaction of sociodemographic factors. Ethn Dis Winter 12 1 (2002) 77-86
6. Yabroff K.R., Breen N., Vernon S.W., Meissner H.I., Freedman A.N., and Ballard-Barbash R. What factors are associated with diagnostic follow-up after abnormal mammograms? Findings from a U.S. National Survey. Cancer Epidemiol Biomarkers Prev 13 5 (2004) 723-732
7. Wang J., Costantino J.P., Tan-Chiu E., Wickerham D.L., Paik S., and Wolmark N. Lower-category benign breast disease and the risk of invasive breast cancer. J Natl Cancer Inst 96 (2004) 616-620
8. Gail M.H., Brinton L.A., Byar D.P., Corle D.K., Green S.B., Schairer C., et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81 24 (1989) 1879-1886
9. Fisher B. Highlights from recent National Surgical Adjuvant Breast and Bowel Project studies in the treatment and prevention of breast cancer. CA Cancer J Clin 49 3 (1999) 159-177
10. Costantino J.P., Gail M.H., Pee D., Anderson S., Redmond C.K., Benichou J., et al. Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 91 18 (1999) 1541-1548
11. National Surgical Adjuvant Breast and Bowel Project members.nsabp.pitt.edu/Prevention_News.asp [the site requires a password].
12. Gwyn K., Bond M.L., Cohen D.S., and Lund M.S. Racial Differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma. Cancer (2004) 100
13. Sung J.F., Alema-Mensah E., and Blumenthal D.S. Inner-city African American women who failed to receive cancer screening following a culturally-appropriate intervention: the role of health insurance. Cancer Detect Prev 26 1 (2002) 28-32
14. Kerker BD, Kim K, Mostashari FM, Frieden TR. Women at risk: The health of women in New York City: New York. NYC Communtiy Health Survey-2002, New York City Department of Health and Mental Hygene; 2005.
15. Susan G. Komen Breast Cancer Foundation The Greater New York City Affiliate. Community needs assessment 2005. [Internal document available on request].
16. Bradley C.J., Given C.W., and Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst 94 7 (2002) 490-496
17. Brawley O.W. Disaggregating the effects of race and poverty on breast cancer outcomes. J Natl Cancer Inst 94 7 (2002) 471-473
18. Jones A.R., Caplan L.S., and Davis M.K. Racial/ethnic differences in the self-reported use of screening mammography. J Commun. Health 28 5 (2003) 303-316
19. Rahman S.M., Dignan M.B., and Shelton B.J. Factors influencing adherence to guidelines for screening mammography among women aged 40 years and older. Ethn Dis Fall 13 4 (2003) 477-484
20. Jones D.A., Cho J.J., Salamon E., and Stefano G.B. Risk factors for breast cancer and the prognosis of African American women: estrogen's role. Med Sci Monit 9 6 (2003) RA111-RA119
21. SEER Cancer Statistics Review, Program Public-use CD-ROM (1973-1998), based on the August 2000 submission [computer program]. Version SEER*Stat 4.0. Bethesda, MD: National Cancer Institute, DCPC, Surveillance Program, Cancer Statistics Branch; 2001.
22. McDavid K., Tucker T.C., Sloggett A., and Coleman M.P. Cancer survival in Kentucky and health insurance coverage. Arch Intern Med 163 18 (2003) 2135-2144
23. Taylor A., and Cheng K.K. Social deprivation and breast cancer. J Public Health Med 25 3 (2003) 228-233
24. Grann V.R., and Jacobson J.S. Health insurance and cancer survival. Arch Intern Med 163 18 (2003) 2123-2124
25. Yabroff K.R., and Gordis L. Does stage at diagnosis influence the observed relationship between socioeconomic status and breast cancer incidence, case-fatality, and mortality?. Soc Sci Med 57 12 (2003) 2265-2279
26. Baker S.G., Erwin D., and Kramer B.S. Estimating the cumulative risk of false positive cancer screenings. BMC Med Res Methodol 3 1 (2003) 11
27. Jemal A., Clegg L.X., Ward E., Ries L.A., Wu X., Jamison P.M., et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 101 1 (2004) 3-27
28. Grann V.R., Jacobson J.S., Troxel A.B., Hershman D., Karp J., Myers C., et al. Barriers to minority participation in breast carcinoma prevention trials. Cancer 104 2 (2005) 374-379
29. Freeman H.P., Muth B.J., and Kerner J.F. Expanding access to cancer screening and clinical follow-up among the medically underserved. Cancer Pract 3 1 (1995) 19-30